In breast cancer, downregulation of α5 integrin impairs tumor cell adhesion to, migration on, and survival within fibronectin (FN) matrices, thereby reducing the incidence of osteolytic lesions in vivo, whereas α5 overexpression enhances bone metastatic colonization (Pantano et al., 2021). Here, FN1 is linked to breast cancer.